Journal of Neuro-Oncology

, Volume 78, Issue 2, pp 153–156 | Cite as

Somnolence syndrome after focal radiation therapy to the pineal region: case report and review of the literature

Clinical--patient studies

Abstract

Somnolence syndrome classically occurs in children after cranial irradiation for acute lymphocytic leukemia. Symptoms include somnolence, fever, nausea and vomiting, and headache. The authors report a 29 year-old female who developed symptoms compatible with the somnolence syndrome after completing radiation therapy for a benign meningioma near the pineal region. Five weeks after completing conformal radiation therapy (54 Gy), she developed profound fatigue, headaches, and 102° fevers. Physical examination and routine laboratory work were unrevealing. Imaging was not performed. Prednisone was prescribed and within 1 week her symptoms had largely resolved. This is the first report of the somnolence syndrome after focal radiation therapy. The possible etiology of the somnolence syndrome is discussed.

Keywords

early delayed encephalopathy pineal region radiation therapy radiation-induced brain injury somnolence syndrome 

Abbreviations

ALL

acute lymphocytic leukemia

RT

radiation therapy

DVH

dose-volume histogram

RAS

reticular activating system

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dropcho EJ: Central nervous system injury by therapeutic irradiation. Neurol Clin 9: 969–988, 1991PubMedGoogle Scholar
  2. 2.
    Druckmann A: Schlafsuct als forge der roentegenbestrahlung beitragzur strahlenempfindlichkeit des gehuna Strahlentherapie 33: 382–384, 1929Google Scholar
  3. 3.
    Freeman JE, Johnston PG, Voke JM: Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukaemia Br Med J 4: 523–525, 1973PubMedCrossRefGoogle Scholar
  4. 4.
    Littman P, Rosenstock J, Gale G, Krisch RE, Meadows A, Sather H, Coccia P, DeCamargo B: The somnolence syndrome in leukemic children following reduced daily dose fractions of cranial radiation Int J Radiat Oncol Biol Phys 10 1851–1853, 1984PubMedGoogle Scholar
  5. 5.
    Mandell LR, Walker RW, Steinherz P, Fuks Z: Reduced incidence of the somnolence syndrome in leukemic children with steroid coverage during prophylactic cranial radiation therapy. Results of a pilot study Cancer 63 1975–1978, 1989PubMedCrossRefGoogle Scholar
  6. 6.
    Uzal D, Ozyar E, Hayran M, Zorlu F, Atahan L, Yetkin S: Reduced incidence of the somnolence syndrome after prophylactic cranial irradiation in children with acute lymphoblastic leukemia Radiother Oncol 48 29–32, 1998CrossRefPubMedGoogle Scholar
  7. 7.
    Goldberg SL, Tefferi A, Rummans TA, Chen MG, Solberg LA, Noel P: Post-irradiation somnolence syndrome in an adult patient following allogeneic bone marrow transplantation Bone Marrow Transplant 9: 499–501, 1992PubMedGoogle Scholar
  8. 8.
    Miyahara M, Azuma E, Hirayama M, Kobayashi M, Hori H, Komada Y, Masuda H: Somnolence syndrome in a child following 1200-cGy total body irradiation in an unrelated bone marrow transplantation Pediatr Hematol Oncol 17: 489–495, 2000CrossRefPubMedGoogle Scholar
  9. 9.
    Leibel S, Sheline G: Tolerance of the Brain and Spinal Cord to Conventional Irradiaiton. In: Gutin P, Leibel S, Sheline G (eds) Radiation Injury to the Nervous System Raven Press, New York, pp 239–241Google Scholar
  10. 10.
    Lampert PW, Davis RL: Delayed effects of radiation on the human central nervous system; “early” and “late” delayed reactions Neurology 14 912–917, 1964PubMedGoogle Scholar
  11. 11.
    Monro P, Mair WG: Radiation effects on the human central nervous system 14 weeks after X-radiation Acta Neuropathol (Berl) 11: 267–274, 1968CrossRefGoogle Scholar
  12. 12.
    Lampert P, Tom MI, Rider WD: Disseminated demyelination of the brain following Co60 (gamma) radiation Arch Pathol 68: 322–330, 1959PubMedGoogle Scholar
  13. 13.
    Krueger JM, Obal F, Jr., Fang J: Humoral regulation of physiological sleep: cytokines and GHRH J Sleep Res 8 (Suppl 1) 53–59, 1999CrossRefPubMedGoogle Scholar
  14. 14.
    Buckner JC, Schomberg PJ, McGinnis WL, Cascino TL, Scheithauer BW, O’Fallon JR, Morton RF, Kuross SA, Mailliard JA, Hatfield AK, Cole JT, Steen PD, Bernath AM: A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma Cancer 92: 420–433, 2001CrossRefPubMedGoogle Scholar
  15. 15.
    Merchant RE, McVicar DW, Merchant LH, Young HF: Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial J Neurooncol 12 75–83, 1992CrossRefPubMedGoogle Scholar
  16. 16.
    Denham JW, Hauer-Jensen M: The radiotherapeutic injury–a complex ‘wound’ Radiother Oncol 63 129–145, 2002CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  1. 1.Department of Radiation OncologyDuke University Medical CenterDurhamUSA
  2. 2.Department of Radiation OncologyDuke University Medical CenterDurhamUSA

Personalised recommendations